Osteotomy Wedge System

FDA 510(k) K252254 · Sinaptic Surgical

Substantially Equivalent

510(k) numberK252254

Submission

Device name
Osteotomy Wedge System
Applicant
Sinaptic Surgical
Slat Lake City, UT, US
Received
July 21, 2025
Decision date
October 17, 2025
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
PLF – Bone Wedge
Device class
Class II (moderate risk)
Regulation
21 CFR 888.3030
Specialty
Orthopedic
Implant
Yes

Intended to be used with ancillary fixation for opening wedge osteotomies or fusion in the ankle, foot, proximal tibia.

Other 510(k)s with product code PLF

510(k)DeviceApplicantDecision
K252733ATLAS™ Expandable Osteotomy Wedge SystemPLF · Traditional MiRus, LLC02/19/2026SE
K251791Auxano® Wedge Fixation SystemPLF · Traditional Auxano Medical, LLC09/25/2025SE
K240461OsteoSinter® EVANS and COTTON wedges and related accessoriesPLF · Abbreviated Ames Medical Prosthetic Solutions, S.A.U.12/06/2024SE
K243231Trigon PEEK HA WedgesPLF · Special Nvision Biomedical Technologies11/08/2024SE
K234116Trigon Trigon HA Stand-Alone Wedge Fixation SystemPLF · Special Nvision Biomedical Technologies01/26/2024SE
K231496TITAN 3-D Wedge SystemPLF · Traditional Paragon 28, Inc.08/22/2023SE
K223226Trigon™ HA Stand-Alone Wedge Fixation SystemPLF · Special Nvision Biomedical Technologies, Inc.12/01/2022SE
K220197Trigon HA Wedge Fixation SystemPLF · Special Nvision Biomedical Technologies, Inc.02/23/2022SE
K201314Restor3d Utility WedgePLF · Traditional Restor3D, Inc.06/17/2021SE
K203445Trigon HA Stand-Alone Wedge Fixation SystemPLF · Special Nvision Biomedical Technologies, Inc.12/21/2020SE

Questions and answers

When was Osteotomy Wedge System cleared by the FDA?

Osteotomy Wedge System (K252254) received a 510(k) decision of Substantially Equivalent on October 17, 2025, 88 days after the submission was received.

What is the product code of K252254?

The FDA product code is PLF – Bone Wedge, a Class II (moderate risk) device regulated under 21 CFR 888.3030.